View drug registration information details.

Items	Registration information
ID	472
No	472
Brand Name	VEXMET 1000 XR
Ingredients	Metformin Hydrochloride USP 1000 mg
Dosage Form	Film coated Tablets
Primary Packaging	Alu-Alu Blister
Storage	Store below 30°C. Protect from light.
Shelf Life	3 YEARS
Pack Size	BOX OF 10 X 10'S
Dispensing Category	PRESCRIPTION
ATC Classification
Pharmaceutical Class	Antidiabetic
Indications	Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.  In adults, VEXMET may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.  In children from 10 years of age and adolescents, VEXMET may be used as monotherapy or in combination with insulin.  A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure
Contraindications	Hypersensitivity to metformin or to any of the excipients.  Diabetic ketoacidosis, diabetic pre-coma.  Renal failure or renal dysfunction (creatinine clearance < 60 ml/min).  Acute conditions with the potential to alter renal function such as: dehydration, severe infection, shock.  Acute or chronic disease which may cause tissue hypoxia such as: cardiac or respiratory failure, recent myocardial infarction, shock.  Hepatic insufficiency, acute alcohol intoxication, alcoholism.
Side Effects	Diarrhea, nausea, vomiting, flatulence Indigestion, abdominal discomfort, Weakness, Myalgia, Chest discomfort, Headache, chills, dizziness, light headedness, Rash, Hypoglycemia, vitamin B 12 levels decreased
Unit Price
EDL	Yes
Description	White colour capsule shape biconvex uncoated extended release tablet
Note
License Owner	VE PRODUCTS (LAO) CO.,LTD
Manufacturer	WEST-COAST PHARMACEUTICAL WORKS LTD
Country	INDIA
Import Registration No	G/25/163
Import Registration Date
Activity	CERTIFICATE RELEASED
Applied Date	2024-10-15
FDD Registration No	12 I 5843/24
FDD Registration Date	2024-12-30
Expiry Date	2029-12-29

Back to drug list